Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00430417 · ClinicalTrials.gov registry record
Bone Metabolism and Parathyroid Hormone-related Protein (PTHrP) Lactation Study
A clinical trial of Bone Diseases, Endocrine, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 49
- Enrollment target
- 1
- Study location
NCT00430417: Completed study of Bone Diseases, Endocrine, sponsored by University of Pittsburgh.
NCT00430417 is a study of Bone Diseases, Endocrine that has completed, run by University of Pittsburgh. The registered enrollment target is 49 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00430417, a study of Bone Diseases, Endocrine, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of the study is to measure bone formation in both lactating and non-lactating post-partum women and compare these to those in healthy non-pregnant controls. The secondary aim is to obtain measurements of Parathyroid Hormone-related Protein (PTHrP), markers of bone resorption, and calcium and vitamin D metabolism in these subjects. The investigators believe that lactating women will have an increase in bone resorption but no increase in bone formation when compared to non-lactating post-partum women and normal controls.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-06 |
What the finished NCT00430417 record still lists
NCT00430417 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 1 condition, with Bone Diseases, Endocrine appearing as the primary indexed condition, and to 0 interventions.
NCT00430417 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00430417 about?
NCT00430417 is a clinical study titled "Bone Metabolism and Parathyroid Hormone-related Protein (PTHrP) Lactation Study". The primary aim of the study is to measure bone formation in both lactating and non-lactating post-partum women and compare these to those in healthy non-pregnant controls. The secondary aim is to obtain measurements of Parathyroid Hormone-related Protein (PTHrP), markers of bone resorption, and cal...
What is the current status of trial NCT00430417?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2007-01. Estimated completion is 2008-06.
What conditions does trial NCT00430417 study?
This clinical trial studies the following conditions: Bone Diseases, Endocrine.
Who is sponsoring clinical trial NCT00430417?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00430417 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Diseases, Endocrine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia